| P50 | author | Kevin M. Prise | Q41601432 |
| | Karl T Butterworth | Q57013779 |
| | Jon P. Golding | Q39855024 |
| P2093 | author name string | Andrey V Solov'yov | |
| | Kaspar Haume | |
| | Małgorzata A Śmiałek | |
| | Nigel J Mason | |
| | Sophie Grellet | |
| | Soraia Rosa | |
| P2860 | cites work | Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. | Q45916200 |
| | Hallmarks of Cancer: The Next Generation | Q22252312 |
| | Renal clearance of quantum dots | Q24657265 |
| | Computational approach for determining the spectrum of DNA damage induced by ionizing radiation | Q27919618 |
| | The journey of a drug-carrier in the body: an anatomo-physiological perspective | Q28250548 |
| | Radiotherapy enhancement with gold nanoparticles | Q28288052 |
| | Fragmentation and plasmid strand breaks in pure and gold-doped DNA irradiated by beams of fast hydrogen atoms | Q64387345 |
| | Dissociative electron attachment to DNA | Q73477093 |
| | Experimental fragmentation studies with 12C therapy beams | Q79404938 |
| | Shock wave initiated by an ion passing through liquid water | Q83183144 |
| | Quantifying tumor-selective radiation dose enhancements using gold nanoparticles: a monte carlo simulation study | Q83693929 |
| | Spectra of secondary electrons generated in water by energetic ions | Q83992064 |
| | Nanoparticle translocation through a lipid bilayer tuned by surface chemistry | Q85637962 |
| | Revealing the mechanism of the low-energy electron yield enhancement from sensitizing nanoparticles | Q86840503 |
| | The biodistribution of gold nanoparticles designed for renal clearance | Q86846759 |
| | Biological modeling of gold nanoparticle enhanced radiotherapy for proton therapy | Q87268495 |
| | Polyethylene glycol backfilling mitigates the negative impact of the protein corona on nanoparticle cell targeting | Q87611530 |
| | Multiscale approach predictions for biological outcomes in ion-beam cancer therapy | Q28830475 |
| | Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells | Q29615461 |
| | Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm | Q29615517 |
| | Biomolecular coronas provide the biological identity of nanosized materials | Q29615557 |
| | Biodamage via shock waves initiated by irradiation with ions | Q30458226 |
| | The cancer glycocalyx mechanically primes integrin-mediated growth and survival | Q30656235 |
| | Effects of cloud-point grafting, chain length, and density of PEG layers on competitive adsorption of ocular proteins. | Q30705598 |
| | Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview | Q33226381 |
| | Tamoxifen-poly(ethylene glycol)-thiol gold nanoparticle conjugates: enhanced potency and selective delivery for breast cancer treatment | Q33516083 |
| | Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability | Q34083937 |
| | A coarse-grained model for polyethylene oxide and polyethylene glycol: conformation and hydrodynamics. | Q34120971 |
| | Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications | Q34259986 |
| | Cell localisation of gadolinium-based nanoparticles and related radiosensitising efficacy in glioblastoma cells | Q34317730 |
| | Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity | Q34595551 |
| | Glucose-coated gold nanoparticles transfer across human brain endothelium and enter astrocytes in vitro | Q35067385 |
| | PEGylated nanoparticles for biological and pharmaceutical applications | Q35082131 |
| | Aptamers: active targeting ligands for cancer diagnosis and therapy | Q35086493 |
| | Treating cancer stem cells and cancer metastasis using glucose-coated gold nanoparticles | Q35201507 |
| | Altered protein expression profile associated with phenotypic changes in lung fibroblasts co-cultured with gold nanoparticle-treated small airway epithelial cells | Q35492955 |
| | The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy. | Q35676729 |
| | Imaging and radiation effects of gold nanoparticles in tumour cells | Q35898483 |
| | Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats | Q36125194 |
| | Antiandrogen gold nanoparticles dual-target and overcome treatment resistance in hormone-insensitive prostate cancer cells. | Q36211542 |
| | Fluorescence-Guided Probes of Aptamer-Targeted Gold Nanoparticles with Computed Tomography Imaging Accesses for in Vivo Tumor Resection | Q36216231 |
| | Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles | Q36319725 |
| | Utilizing the folate receptor for active targeting of cancer nanotherapeutics | Q36463444 |
| | Nanoparticle location and material dependent dose enhancement in X-ray radiation therapy | Q36584987 |
| | Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines. | Q36900208 |
| | Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy | Q36952188 |
| | Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle. | Q37037910 |
| | Factors affecting the clearance and biodistribution of polymeric nanoparticles. | Q37146591 |
| | Glucose conjugation for the specific targeting and treatment of cancer | Q37200539 |
| | Size-Dependent Endocytosis of Nanoparticles | Q37259900 |
| | On the role of low-energy electrons in the radiosensitization of DNA by gold nanoparticles | Q37313429 |
| | Cationic nanoparticles have superior transvascular flux into solid tumors: insights from a mathematical model | Q37457535 |
| | Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer | Q37616813 |
| | Size-dependent cytotoxicity of gold nanoparticles | Q40061688 |
| | Cell selective response to gold nanoparticles | Q40119290 |
| | Cluster effects within the local effect model | Q40168152 |
| | Cellular uptake and toxicity of Au55 clusters | Q40189259 |
| | The use of gold nanoparticles to enhance radiotherapy in mice | Q40499366 |
| | Improving proton therapy by metal-containing nanoparticles: nanoscale insights | Q40511266 |
| | Effect of photon beam energy, gold nanoparticle size and concentration on the dose enhancement in radiation therapy. | Q40552278 |
| | Nanoparticle-induced apoptosis propagates through hydrogen-peroxide-mediated bystander killing: insights from a human intestinal epithelium in vitro model | Q42473126 |
| | The role of mitochondrial function in gold nanoparticle mediated radiosensitisation. | Q42878512 |
| | Accuracy of the local effect model for the prediction of biologic effects of carbon ion beams in vitro and in vivo. | Q43420808 |
| | Comparison of DNA breaks at entrance channel and Bragg peak induced by fast C6+ ions--influence of the addition of platinum atoms on DNA. | Q44110435 |
| | Negotiation of intracellular membrane barriers by TAT-modified gold nanoparticles | Q44156889 |
| | On the interactions of free radicals with gold nanoparticles | Q44488802 |
| | Nanoscale energy deposition by X-ray absorbing nanostructures | Q44491096 |
| | The radiobiological and physical basis for radiotherapy with protons and heavier ions | Q44945190 |
| | Gadolinium-based nanoparticles to improve the hadrontherapy performances. | Q45917006 |
| | Gold nanoparticles functionalization notably decreases radiosensitization through hydroxyl radical production under ionizing radiation | Q46805989 |
| | Gold nanoparticle-initiated free radical oxidations and halogen abstractions | Q46944938 |
| | Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy. | Q47304949 |
| | Measuring the density of DNA films using ultraviolet-visible interferometry. | Q51187809 |
| | Quantitative analysis of isolated and clustered DNA damage induced by gamma-rays, carbon ion beams, and iron ion beams. | Q51791794 |
| | A complete dielectric response model for liquid water: a solution of the Bethe ridge problem. | Q51968524 |
| | Treatment planning for heavy-ion radiotherapy: physical beam model and dose optimization. | Q52070616 |
| | Toxicity of Gold Nanoparticles Functionalized with Cationic and Anionic Side Chains | Q56443622 |
| | Dense PEG layers for efficient immunotargeting of nanoparticles to cancer cells | Q57367356 |
| | Ion beam transport calculations and treatment plans in particle therapy | Q57780876 |
| | Measurement of DNA Damage by Electrons with Energies between 25 and 4000 EV | Q58313838 |
| | Influence of Serum Supplemented Cell Culture Medium on Colloidal Stability of Polymer Coated Iron Oxide and Polystyrene Nanoparticles With Impact on Cell Interactions In Vitro | Q58493165 |
| | Enhancement of radiation effect by heavy elements | Q37675264 |
| | To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery | Q37783377 |
| | Nanomaterials: applications in cancer imaging and therapy. | Q37857064 |
| | In vivo biodistribution of nanoparticles | Q37906630 |
| | Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective | Q37950467 |
| | The effect of nanoparticle size, shape, and surface chemistry on biological systems | Q38004588 |
| | Physical basis and biological mechanisms of gold nanoparticle radiosensitization. | Q38024325 |
| | Gold nanoparticles in theranostic oncology: current state-of-the-art | Q38035034 |
| | DNA double strand break repair: a radiation perspective | Q38073315 |
| | Radiosensitising nanoparticles as novel cancer therapeutics--pipe dream or realistic prospect? | Q38123288 |
| | The role of oxidative DNA damage in radiation induced bystander effect | Q38188285 |
| | The potential effectiveness of nanoparticles as radio sensitizers for radiotherapy | Q38208842 |
| | Engineered nanoparticles for drug delivery in cancer therapy | Q38258048 |
| | Evidence-based estimates of the demand for radiotherapy. | Q38279405 |
| | Current trends in using polymer coated gold nanoparticles for cancer therapy. | Q38363360 |
| | Understanding nanoparticle cellular entry: A physicochemical perspective | Q38364605 |
| | Enhanced relative biological effectiveness of proton radiotherapy in tumor cells with internalized gold nanoparticles | Q38366112 |
| | Protein disulphide isomerase as a target for nanoparticle-mediated sensitisation of cancer cells to radiation | Q38778110 |
| | Cancer Therapeutic Effects of Titanium Dioxide Nanoparticles Are Associated with Oxidative Stress and Cytokine Induction | Q38826350 |
| | Folate-conjugated gold nanoparticle as a new nanoplatform for targeted cancer therapy. | Q38840971 |
| | Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface | Q39207806 |
| | Cell type-dependent uptake, localization, and cytotoxicity of 1.9 nm gold nanoparticles. | Q39330773 |
| | Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake | Q39423946 |
| | Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment. | Q39447613 |
| | Nanodosimetric effects of gold nanoparticles in megavoltage radiation therapy | Q39472564 |
| | Pancreatic carcinoma cells are susceptible to noninvasive radio frequency fields after treatment with targeted gold nanoparticles. | Q39694145 |
| | Enhancement of cell radiation sensitivity by pegylated gold nanoparticles. | Q39749727 |
| | Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-198AuNP nanoconstruct in prostate tumor-bearing mice. | Q39774435 |
| | Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles | Q39787205 |
| | Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? | Q39803936 |
| | Intracellular uptake, transport, and processing of nanostructures in cancer cells. | Q39845468 |
| | Mediating tumor targeting efficiency of nanoparticles through design | Q39864411 |
| | Her2-targeted pegylated liposomal doxorubicin: retention of target-specific binding and cytotoxicity after in vivo passage | Q39866499 |
| | Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines | Q39874006 |
| | Platinum nanoparticles: a promising material for future cancer therapy? | Q39906667 |
| | Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy. | Q39975675 |
| | Parameters governing gold nanoparticle X-ray radiosensitization of DNA in solution | Q39982631 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanoparticle | Q61231 |
| | adaptive radiation therapy | Q180507 |
| P304 | page(s) | 8 | |
| P577 | publication date | 2016-01-01 | |
| P1433 | published in | Cancer Nanotechnology | Q26853896 |
| P1476 | title | Gold nanoparticles for cancer radiotherapy: a review | |
| P478 | volume | 7 | |